Anaplastic Thyroid Carcinoma

• CLINICAL_TRIALS trial_result · 2019-08-28
  Clinical Trial Update: Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating pembrolizumab with chemotherapy and radiation, with or without surgery, in anaplastic thyroid carcinoma; study comp…

• CLINICAL_TRIALS trial_result · 2017-08-03
  Clinical Trial Update: Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients [Phase 2]

  This update reports the completion of Bayer-sponsored Phase II trial evaluating sorafenib in Japanese patients with anaplastic or medullary …

• CLINICAL_TRIALS withdrawal · 2016-01-26
  Clinical Trial Update: A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers [Phase 1]

  A Phase 1 trial evaluating adalimumab in combination with chemotherapy and radiotherapy for anaplastic thyroid carcinoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2015-12-31
  Clinical Trial Update: A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) [Phase 1, Phase 2]

  A Phase I/II clinical trial evaluating Crolibulin (EPC2407) in combination with cisplatin in adults with solid tumors, focusing on anaplasti…

• CLINICAL_TRIALS trial_result · 2014-06-09
  Clinical Trial Update: Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer [Phase 2, Phase 3]

  A phase 2/3 trial evaluating combretastatin with paclitaxel and carboplatin for anaplastic thyroid carcinoma was terminated, with results po…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2014-04-21
  Clinical Trial Update: Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma [Phase 2]

  A Phase 2 trial evaluating imatinib (Gleevec) in patients with anaplastic thyroid carcinoma was terminated, with results posted in 2014.

• CLINICAL_TRIALS trial_result · 2013-02-28
  Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]

  A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.

• CLINICAL_TRIALS research · 2011-11-21
  Clinical Trial Update: Review of Multimodality Management of Anaplastic Thyroid Cancer

  This document provides an overview of multimodality management strategies for anaplastic thyroid carcinoma, summarizing current treatment ap…

• CLINICAL_TRIALS trial_result · 2010-06-11
  Clinical Trial Update: Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]

  Phase 2 trial update for Combretastatin A4 Phosphate in advanced anaplastic thyroid carcinoma (a form of head and neck cancer); the study st…

• CLINICAL_TRIALS trial_result · 2010-06-11
  Clinical Trial Update: Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer [Phase 1, Phase 2]

  A terminated Phase 1/2 trial evaluating induction chemotherapy with doxorubicin and cisplatin followed by combretastatin A4 phosphate and ra…